Neoadjuvant immunotherapy offers a survival benefit in specific subtypes of patients but seems to offer no benefit in the ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

Rahway, N.J.-based Merck said a trial of the drug given under-the-skin and combined with chemotherapy proved to be as effective as when given intravenously. Merck said it would discuss the results ...

Merck (NYSE:MRK) announced Tuesday that a subcutaneously delivered version of its blockbuster cancer therapy pembrolizumab ...

Addison Davis has been forced into adulthood faster than any teenager ever should be. She's handled it all better than anyone ...